English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Researchers identify key autoimmune driver in inflammatory bowel disease patients
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Local trade groups urged to support life sciences amid federal funding uncertainty
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

ASCO conference highlights new cancer therapies and key clinical trial results
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Study finds five-minute prayer session reduces pain and anxiety in primary care patients
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

AI chatbots provide 76% accuracy in answering health questions, Penn State study finds
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Apogee Therapeutics secures $1.3B royalty deal, shares fall after eczema drug data
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Physician executive calls for collaborative care plans to meet 2027 health targets
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Kailera Therapeutics enters catalyst-rich period after record-breaking IPO

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes